Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial.
Effect of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality: a randomized clinical trial.
复制标题
DOI:
10.1001/jama.2014.8266
复制
发表时间:
2014-08-13
影响因子:
120.7
通讯作者:
Hoff, Geir
中科院分区:
文献类型:
--
作者:
Holme, Oyvind;Loberg, Magnus;Kalager, Mette;Bretthauer, Michael;Hernan, Miguel A.;Aas, Eline;Eide, Tor J.;Skovlund, Eva;Schneede, Jorn;Tveit, Kjell Magne;Hoff, Geir
Colorectal cancer is a major health burden. Screening is recommended in many countries. Estimate the effectiveness of flexible sigmoidoscopy screening on colorectal cancer incidence and mortality in a population-based trial. Randomized controlled trial in individuals aged 50–64 years. Screening was performed in 1999–2000 (55–64 year age-group) and 2001 (50–54 year age-group). End of follow-up: Dec 31st 2011. Population of Oslo city and Telemark County, Norway. 100,210 individuals were identified in the screening areas. 1,415 individuals were excluded due to prior colorectal cancer, emigration, or death. Three individuals could not be traced in the population registry. Individuals randomized to the screening group were invited to screening. Within the screening group, individuals were randomized 1:1 to once-only flexible sigmoidoscopy or combination of once-only flexible sigmoidoscopy and fecal occult blood-testing (FOBT). Individuals with positive screening test (cancer, adenoma, polyp ≥10 mm, or positive FOBT) were offered colonoscopy. The control group received no intervention. Colorectal cancer incidence and mortality. 98,792 individuals were included in the intention to screen analyses; 78,220 in the control group and 20,572 in the screening group (10,283 randomized to flexible sigmoidoscopy and 10,289 to flexible sigmoidoscopy and FOBT). Compliance with screening was 63%. After median 10.9 years, 71 individuals had died from colorectal cancer in the screening group, and 330 in the control group (31.4 vs. 43.1 deaths, absolute rate difference 11.7 (95% CI 3.0–20.4) per 100,000 person-years); hazard ratio [HR] 0.73 (95% confidence interval [CI] 0.56–0.94). Colorectal cancer was diagnosed in 253 individuals in the screening group, and 1,086 in the control group (112.6 vs. 141.0 cases, absolute rate difference: 28.4 (95% CI 12.1–44.7) per 100,000 person-years); HR 0.80 (95% CI 0.70–0.92). Colorectal cancer incidence was reduced in both the 50–54 year age-group (HR 0.68; 95% CI 0.49–0.94) and the 55–64 year age-group (HR 0.83; 95% CI 0.71–0.96). There was no difference between the flexible sigmoidoscopy only and the flexible sigmoidoscopy/FOBT screening groups. In Norway, once-only flexible sigmoidoscopy screening or flexible sigmoidoscopy and FOBT reduced colorectal cancer incidence and mortality on a population level compared with no screening. Screening was effective both in the 50–54 and the 55–64 year age-group. ClinicalTrials identifier NTC00119912, http://clinicaltrials.gov
登录
查看更多内容
影响因子:
105.7
作者:
Hoff, Geir;Grotmol, Tom;Bretthauer, Michael
通讯作者:
Bretthauer, Michael
影响因子:
5.5
作者:
Lansdorp-Vogelaar I;Knudsen AB;Brenner H
通讯作者:
Brenner H
影响因子:
6.2
作者:
MUTO, T;BUSSEY, HJR;MORSON, BC
通讯作者:
MORSON, BC
影响因子:
24.5
作者:
Gondal, G;Grotmol, T;Hoff, G
通讯作者:
Hoff, G
影响因子:
8.4
作者:
Larsen, Inger Kristin;Smastuen, Milada;Moller, Bjorn
通讯作者:
Moller, Bjorn